17β-estradiol

Overview

17β-Estradiol (E2) is the primary and most biologically potent endogenous estrogen in humans, classified as a steroid hormone biosynthesized predominantly in the ovaries, with secondary production in the adrenal cortex, placenta, testes, and peripheral adipose tissue. It is derived from testosterone via aromatization, a reaction catalyzed by the enzyme aromatase (CYP19A1), and exerts its effects principally through binding to estrogen receptors ERα and ERβ — nuclear transcription factors that regulate gene expression across a broad array of tissues including the reproductive tract, bone, cardiovascular system, and central nervous system. Chemically designated as estra-1,3,5(10)-triene-3,17β-diol (molecular formula C₁₈H₂₄O₂), E2 maintains characteristic phenolic A-ring and β-hydroxyl configurations that confer high receptor affinity. Its role extends well beyond reproductive physiology: E2 modulates cell proliferation, apoptosis, vascular tone, lipid metabolism, and neuroprotection, making it a target of sustained interest in oncology, endocrinology, reproductive medicine, and environmental toxicology.

Beyond its endogenous roles, 17β-estradiol is recognized as an environmental contaminant of emerging concern (EC). Excreted by humans and livestock and incompletely removed by conventional water treatment, E2 enters aquatic ecosystems where, even at trace concentrations (nanograms per liter), it acts as an endocrine-disrupting chemical (EDC), perturbing hormonal signaling in wildlife and raising concern about indirect human exposure through drinking water and food chains.

Focus of Latest Publications

Recent literature situates 17β-estradiol at the intersection of cancer biology, reproductive endocrinology, environmental monitoring, and clinical obstetrics, reflecting the breadth of physiological and ecological systems in which it operates.

Colorectal cancer and receptor-independent signaling. A 2026 study published in Clinical Science examined the effects of selective estrogen receptor modulators on colorectal cancer (CRC), with estradiol serving as the reference estrogenic ligand. The investigation probed the relationship between estrogen signaling and insulin-like growth factor binding protein-5 (IGFBP-5) expression, a protein with prognostic relevance in CRC. Notably, both estradiol and 27-hydroxycholesterol (27-OHC) suppressed CRC cell proliferation and reduced IGFBP-5 expression, yet this suppression operated independently of ERβ, suggesting that at least some antiproliferative actions of estrogenic compounds in colorectal tissue proceed through non-canonical, ERβ-independent pathways. These findings complicate the conventional receptor-centric model of E2 action and point to alternative effectors worthy of further investigation.

Aromatase inhibition and all-male fish production. In aquaculture research, 17β-estradiol served as a key hormonal endpoint in a 2026 study evaluating anastrozole — a third-generation aromatase inhibitor — as a tool for producing all-male Nile tilapia (Oreochromis niloticus) through immersion treatment. Because aromatase converts testosterone to estradiol, pharmacological inhibition with anastrozole predictably suppressed circulating estradiol while simultaneously elevating testosterone levels, confirming effective aromatase blockade. Histological examination of gonadal tissue corroborated the hormonal data. The study demonstrated that discrete anastrozole immersion is a viable, chemical-sparing approach to sex control in commercial tilapia aquaculture, with E2 plasma levels serving as the primary biomarker of treatment efficacy.

Environmental detection as an emerging contaminant. Two independent analytical chemistry studies highlight mounting concern over E2 as an environmental EDC. A broad survey published in Analytical Chemistry (2026) evaluated graphene-based electrochemical platforms for detecting pharmaceutical and agricultural contaminants in water, grouping estradiol alongside Diclofenac, ibuprofen, glyphosate, amoxicillin, and bisphenol A as priority targets. Under optimized electro-Fenton conditions, estradiol exhibited detection responses comparable to these structurally diverse contaminants, underscoring the versatility of the sensing approach irrespective of molecular architecture. A separate study in Biosensors & Bioelectronics (2026) explicitly framed 17β-estradiol and bisphenol A as archetypal EDCs, noting that even trace environmental concentrations carry significant health risk and motivating development of a self-calibrated ratiometric biosensor for their simultaneous detection.

Early pregnancy outcome prediction. A machine-learning study published in PLoS ONE (2026) incorporated serum estradiol (E2) alongside β-human chorionic gonadotropin (β-hCG) and progesterone as dynamic predictive biomarkers for early pregnancy outcomes. Both baseline E2 concentrations and their temporal trajectories contributed to model performance, reflecting E2's integral role in luteal support and early placentation. This application exemplifies the growing use of hormonal panels in computational obstetrics.

Subarachnoid hemorrhage risk under hypo-estrogenic conditions. A 2026 BMJ case report described subarachnoid hemorrhage occurring during dienogest (DNG) therapy in a premenopausal patient with multiple cerebrovascular risk factors. Dienogest, a progestogen used in endometriosis management, induces a hypo-estrogenic state, with serum estradiol reportedly falling to approximately 30 pg/mL after one year of use. The case raised the hypothesis that sustained estradiol suppression may increase aneurysm rupture risk by attenuating E2's known vasculoprotective effects on cerebral arterial walls.

Key Publications

Jun Overnight wakefulness impairs next-day postprandial glucose in young women independent of sex hormones. (The Journal of clinical endocrinology and metabolism, 2026, PMID 41618682): "Estradiol and progesterone may influence glucose regulation, but it remains unclear whether ovarian hormone levels modulate night shift-induced impairments in glucose metabolism."
Jun Unravelling the effects of selective estrogen receptor modulators on colorectal cancer: a prognostic role for insulin-like growth factor binding protein-5. (Clinical science (London, England : 1979), 2026, PMID 42047268): "Both estrogen and 27-OHC suppressed CRC cell proliferation and IGFBP-5 expression, but this was independent of ERβ."
May All-male production in Nile tilapia (Oreochromis niloticus) through discrete anastrozole immersion: hormonal and histological insights. (Fish physiology and biochemistry, 2026, PMID 42171893): "Aromatase inhibition was confirmed by marked reductions in circulating estradiol alongside significant increases in testosterone."
May Graphene-Based Electrochemical Sensors for the Determination of Pharmaceutical- and Agricultural-Based Emerging Contaminants in Water. (Analytical chemistry, 2026, PMID 42060697): "Under optimized electro-Fenton (EF) conditions, additional ECs—including diclofenac, ibuprofen, glyphosate, and estradiol—showed comparable responses, demonstrating broad applicability independent of molecular structure."
May Synergistic coupling of a spherical nucleic acid DNA walker and a redox cascade for self-calibrated ratiometric detection of endocrine disruptors. (Biosensors & bioelectronics, 2026, PMID 41604759): "Endocrine-disrupting chemicals (EDCs), such as 17β-estradiol (E2) and bisphenol A (BPA), are pervasive environmental contaminants that pose significant health risks even at trace concentrations."
Jan Development of machine learning models for predicting early pregnancy outcomes based on β-hCG, progesterone, and estradiol. (PloS one, 2026, PMID 42044144): "This study aims to develop a machine learning model for predicting early pregnancy outcomes by combining baseline levels and dynamic changes of β-human chorionic gonadotropin (β-hCG), progesterone (P), and estradiol (E2)."
Apr Subarachnoid haemorrhage during premenopausal dienogest therapy in a patient with multiple risk factors. (BMJ case reports, 2026, PMID 42031397): "DNG induces a hypooestrogenic state, with serum oestradiol levels dropping to 30 pg/mL after 1 year, potentially increasing the risk of aneurysm rupture."